Published in N Engl J Med on December 22, 2011
Predictors of Disease Progression in Primary Focal Segmental Glomerulosclerosis | NCT03126201
Abatacept in B7-1-positive proteinuric kidney disease. N Engl J Med (2013) 5.62
Association of histologic variants in FSGS clinical trial with presenting features and outcomes. Clin J Am Soc Nephrol (2012) 2.42
Proteinuria impairs podocyte regeneration by sequestering retinoic acid. J Am Soc Nephrol (2013) 2.09
Focal segmental glomerulosclerosis is induced by microRNA-193a and its downregulation of WT1. Nat Med (2013) 1.98
Defining cell-type specificity at the transcriptional level in human disease. Genome Res (2013) 1.96
Molecular mechanisms of diabetic kidney disease. J Clin Invest (2014) 1.80
Pro: 'The usefulness of biomarkers in glomerular diseases'. The problem: moving from syndrome to mechanism--individual patient variability in disease presentation, course and response to therapy. Nephrol Dial Transplant (2015) 1.73
Gq signaling causes glomerular injury by activating TRPC6. J Clin Invest (2015) 1.54
A role for genetic susceptibility in sporadic focal segmental glomerulosclerosis. J Clin Invest (2016) 1.48
Endothelial mitochondrial oxidative stress determines podocyte depletion in segmental glomerulosclerosis. J Clin Invest (2014) 1.46
Cubilin and amnionless mediate protein reabsorption in Drosophila nephrocytes. J Am Soc Nephrol (2012) 1.42
A circulating antibody panel for pretransplant prediction of FSGS recurrence after kidney transplantation. Sci Transl Med (2014) 1.39
An in vivo functional analysis system for renal gene discovery in Drosophila pericardial nephrocytes. J Am Soc Nephrol (2013) 1.34
Divergent functions of the Rho GTPases Rac1 and Cdc42 in podocyte injury. Kidney Int (2013) 1.27
Tracking the fate of glomerular epithelial cells in vivo using serial multiphoton imaging in new mouse models with fluorescent lineage tags. Nat Med (2013) 1.22
Serum soluble urokinase-type plasminogen activator receptor levels and idiopathic FSGS in children: a single-center report. Clin J Am Soc Nephrol (2013) 1.20
A bigger picture: classical cadherins and the dynamic actin cytoskeleton. Nat Rev Mol Cell Biol (2012) 1.18
Recent progress in the pathophysiology and treatment of FSGS recurrence. Am J Transplant (2013) 1.13
Podocyte repopulation by renal progenitor cells following glucocorticoids treatment in experimental FSGS. Am J Physiol Renal Physiol (2013) 1.13
Clinical Features and Histology of Apolipoprotein L1-Associated Nephropathy in the FSGS Clinical Trial. J Am Soc Nephrol (2015) 1.12
Angiotensin II has acute effects on TRPC6 channels in podocytes of freshly isolated glomeruli. Kidney Int (2014) 1.03
Bone marrow-derived immature myeloid cells are a main source of circulating suPAR contributing to proteinuric kidney disease. Nat Med (2016) 1.02
Role of Rac1-mineralocorticoid-receptor signalling in renal and cardiac disease. Nat Rev Nephrol (2013) 1.01
Urinary soluble urokinase receptor levels are elevated and pathogenic in patients with primary focal segmental glomerulosclerosis. BMC Med (2014) 0.98
The direction and role of phenotypic transition between podocytes and parietal epithelial cells in focal segmental glomerulosclerosis. Am J Physiol Renal Physiol (2013) 0.98
The role of the immune system in idiopathic nephrotic syndrome: a review of clinical and experimental studies. Inflamm Res (2014) 0.98
Relationship between serum soluble urokinase plasminogen activator receptor level and steroid responsiveness in FSGS. Clin J Am Soc Nephrol (2014) 0.96
Fibrosis: a key feature of Fabry disease with potential therapeutic implications. Orphanet J Rare Dis (2013) 0.95
Familial clustering of ESRD in the Norwegian population. Clin J Am Soc Nephrol (2014) 0.95
Causes and pathogenesis of focal segmental glomerulosclerosis. Nat Rev Nephrol (2014) 0.94
Podocyte injury-driven intracapillary plasminogen activator inhibitor type 1 accelerates podocyte loss via uPAR-mediated β1-integrin endocytosis. Am J Physiol Renal Physiol (2015) 0.92
Nephrotoxic effects of common and emerging drugs of abuse. Clin J Am Soc Nephrol (2014) 0.91
ADCK4 "reenergizes" nephrotic syndrome. J Clin Invest (2013) 0.91
Secondary focal and segmental glomerulosclerosis associated with single-nucleotide polymorphisms in the genes encoding complement factor H and C3. Am J Kidney Dis (2012) 0.91
Decreased glomerular filtration as the primary factor of elevated circulating suPAR levels in focal segmental glomerulosclerosis. Pediatr Nephrol (2014) 0.91
Focal segmental glomerulosclerosis: molecular genetics and targeted therapies. BMC Nephrol (2015) 0.90
Developing therapeutic 'arrows' with the precision of William Tell: the time has come for targeted therapies in kidney disease. Curr Opin Nephrol Hypertens (2015) 0.88
The structural and functional organization of the podocyte filtration slits is regulated by Tjp1/ZO-1. PLoS One (2014) 0.87
Mutations in PAX2 associate with adult-onset FSGS. J Am Soc Nephrol (2014) 0.87
The glomerular filtration barrier: components and crosstalk. Int J Nephrol (2012) 0.87
Is there clinical value in measuring suPAR levels in FSGS? Clin J Am Soc Nephrol (2013) 0.87
Pathophysiology and treatment of focal segmental glomerulosclerosis: the role of animal models. BMC Nephrol (2013) 0.85
Urinary CD80 levels as a diagnostic biomarker of minimal change disease. Pediatr Nephrol (2014) 0.85
Women, kidney disease, and pregnancy. Adv Chronic Kidney Dis (2013) 0.84
Podocyte dedifferentiation: a specialized process for a specialized cell. Front Endocrinol (Lausanne) (2014) 0.84
Recessive nephrocerebellar syndrome on the Galloway-Mowat syndrome spectrum is caused by homozygous protein-truncating mutations of WDR73. Brain (2015) 0.84
A patient with nephrotic-range proteinuria and focal global glomerulosclerosis. Clin J Am Soc Nephrol (2013) 0.84
Insights into the renal pathogenesis in Schimke immuno-osseous dysplasia: A renal histological characterization and expression analysis. J Histochem Cytochem (2014) 0.83
Sirtuin1 Maintains Actin Cytoskeleton by Deacetylation of Cortactin in Injured Podocytes. J Am Soc Nephrol (2014) 0.82
The primary glomerulonephritides: a systems biology approach. Nat Rev Nephrol (2013) 0.82
Glycogen synthase kinase 3β orchestrates microtubule remodeling in compensatory glomerular adaptation to podocyte depletion. J Biol Chem (2014) 0.82
Neph1 is reduced in primary focal segmental glomerulosclerosis, minimal change nephrotic syndrome, and corresponding experimental animal models of adriamycin-induced nephropathy and puromycin aminonucleoside nephrosis. Nephron Extra (2014) 0.82
Discovery of new glomerular disease-relevant genes by translational profiling of podocytes in vivo. Kidney Int (2014) 0.82
Danger control programs cause tissue injury and remodeling. Int J Mol Sci (2013) 0.82
Circulating Permeability Factors in Primary Focal Segmental Glomerulosclerosis: A Review of Proposed Candidates. Biomed Res Int (2016) 0.82
A circulating permeability factor in focal segmental glomerulosclerosis: the hunt continues. Clin Kidney J (2015) 0.81
Podocyte injury-driven lipid peroxidation accelerates the infiltration of glomerular foam cells in focal segmental glomerulosclerosis. Am J Pathol (2015) 0.81
suPAR and Team Nephrology. BMC Med (2014) 0.81
Issues in solid-organ transplantation in children: translational research from bench to bedside. Clinics (Sao Paulo) (2014) 0.81
Exome sequencing and in vitro studies identified podocalyxin as a candidate gene for focal and segmental glomerulosclerosis. Kidney Int (2013) 0.81
Deficiency of the planar cell polarity protein Vangl2 in podocytes affects glomerular morphogenesis and increases susceptibility to injury. J Am Soc Nephrol (2014) 0.81
Treatment with Glucocorticoids or Calcineurin Inhibitors in Primary FSGS. Clin J Am Soc Nephrol (2016) 0.81
Pathogenesis of Focal Segmental Glomerulosclerosis. J Pathol Transl Med (2016) 0.81
Novel mutations in the inverted formin 2 gene of Chinese families contribute to focal segmental glomerulosclerosis. Kidney Int (2015) 0.80
Dynamic changes of urinary proteins in a focal segmental glomerulosclerosis rat model. Proteome Sci (2014) 0.80
Highlights for the management of a child with proteinuria and hematuria. Int J Pediatr (2012) 0.80
TRPC6 G757D Loss-of-Function Mutation Associates with FSGS. J Am Soc Nephrol (2016) 0.79
Could Autophagic Exhaustion Be a Final Common Pathway for Podocytopathy in FSGS? J Am Soc Nephrol (2014) 0.79
Focal and segmental glomerulosclerosis: clinical and kidney biopsy correlations. Clin Kidney J (2014) 0.79
Abatacept in B7-1-positive proteinuric kidney disease. N Engl J Med (2014) 0.79
Calcium, TRPC channels, and regulation of the actin cytoskeleton in podocytes: towards a future of targeted therapies. Pediatr Nephrol (2015) 0.79
The novel diagnostic biomarkers for focal segmental glomerulosclerosis. Int J Nephrol (2014) 0.79
The Caenorhabditis elegans Excretory System: A Model for Tubulogenesis, Cell Fate Specification, and Plasticity. Genetics (2016) 0.79
Historical milestones in renal pathology. Virchows Arch (2012) 0.79
Viruses and collapsing glomerulopathy: a brief critical review. Clin Kidney J (2012) 0.79
The Evidence-Based Approach to Adult-Onset Idiopathic Nephrotic Syndrome. Front Pediatr (2015) 0.79
Clinical features and outcomes of focal segmental glomerulosclerosis pathologic variants in Korean adult patients. BMC Nephrol (2014) 0.78
Update on the treatment of focal segmental glomerulosclerosis in renal transplantation. World J Transplant (2016) 0.78
Gene-level integrated metric of negative selection (GIMS) prioritizes candidate genes for nephrotic syndrome. PLoS One (2013) 0.78
The Influence and Role of Microbial Factors in Autoimmune Kidney Diseases: A Systematic Review. J Immunol Res (2015) 0.78
Collapsing focal segmental glomerulosclerosis: Current concepts. World J Nephrol (2012) 0.78
Glomerular Density and Volume in Renal Biopsy Specimens of Children with Proteinuria Relative to Preterm Birth and Gestational Age. Clin J Am Soc Nephrol (2017) 0.78
Congenital nephrotic syndrome and recurrence of proteinuria after renal transplantation. Pediatr Nephrol (2014) 0.78
Proteomic analysis of formalin-fixed paraffin-embedded glomeruli suggests depletion of glomerular filtration barrier proteins in two-kidney, one-clip hypertensive rats. Nephrol Dial Transplant (2014) 0.78
Links between coagulation, inflammation, regeneration, and fibrosis in kidney pathology. Lab Invest (2016) 0.77
The role of plasma exchange in treating post-transplant focal segmental glomerulosclerosis: A systematic review and meta-analysis of 77 case-reports and case-series. BMC Nephrol (2016) 0.77
Podocyte injury: the role of proteinuria, urinary plasminogen, and oxidative stress. Am J Physiol Renal Physiol (2016) 0.77
Risk factors of venous thromboembolism in focal segmental glomerulosclerosis with nephrotic syndrome. Clin Exp Nephrol (2015) 0.77
Clinical Significance of IgM and C3 Glomerular Deposition in Primary Focal Segmental Glomerulosclerosis. Clin J Am Soc Nephrol (2016) 0.77
Foam cells and the pathogenesis of kidney disease. Curr Opin Nephrol Hypertens (2015) 0.76
FSGS Recurrence in Adults after Renal Transplantation. Biomed Res Int (2016) 0.76
Mineralocorticoid receptor activation as an etiological factor in kidney diseases. Clin Exp Nephrol (2013) 0.76
Human Urine Proteomics: Analytical Techniques and Clinical Applications in Renal Diseases. Int J Proteomics (2015) 0.76
The podocyte as a direct target for treatment of glomerular disease? Am J Physiol Renal Physiol (2016) 0.76
Structural Analysis of the Myo1c and Neph1 Complex Provides Insight into the Intracellular Movement of Neph1. Mol Cell Biol (2016) 0.76
Renal biopsy: use of biomarkers as a tool for the diagnosis of focal segmental glomerulosclerosis. Dis Markers (2014) 0.75
Dosage-dependent Role of RAC1 in Podocyte Injury. Am J Physiol Renal Physiol (2016) 0.75
Novel biomarkers in glomerular disease. Adv Chronic Kidney Dis (2014) 0.75
Acute renal failure as the presenting sign of disseminated intravascular coagulation in a patient with metastatic prostate cancer. Int J Nephrol Renovasc Dis (2013) 0.75
Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice. J Clin Invest (2002) 5.42
Prevalence and associations of 25-hydroxyvitamin D deficiency in US children: NHANES 2001-2004. Pediatrics (2009) 3.62
Predictors of relapse and treatment resistance in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis. Ann Intern Med (2005) 3.18
Autoimmunity is triggered by cPR-3(105-201), a protein complementary to human autoantigen proteinase-3. Nat Med (2003) 2.85
Differential gene expression following early renal ischemia/reperfusion. Kidney Int (2003) 2.60
Clinical trial of focal segmental glomerulosclerosis in children and young adults. Kidney Int (2011) 2.43
Association of histologic variants in FSGS clinical trial with presenting features and outcomes. Clin J Am Soc Nephrol (2012) 2.42
Alternative complement pathway in the pathogenesis of disease mediated by anti-neutrophil cytoplasmic autoantibodies. Am J Pathol (2007) 2.41
Predictors of treatment resistance and relapse in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis: comparison of two independent cohorts. Arthritis Rheum (2008) 2.26
Increased prevalence of renal and urinary tract anomalies in children with congenital hypothyroidism. J Pediatr (2008) 2.20
Venous thromboembolism in patients with membranous nephropathy. Clin J Am Soc Nephrol (2011) 2.18
Classification of antineutrophil cytoplasmic autoantibody vasculitides: the role of antineutrophil cytoplasmic autoantibody specificity for myeloperoxidase or proteinase 3 in disease recognition and prognosis. Arthritis Rheum (2012) 2.17
Effect of an oral Shiga toxin-binding agent on diarrhea-associated hemolytic uremic syndrome in children: a randomized controlled trial. JAMA (2003) 2.04
Pathogenesis of antineutrophil cytoplasmic autoantibody-associated small-vessel vasculitis. Annu Rev Pathol (2013) 2.02
Epitope specificity determines pathogenicity and detectability in ANCA-associated vasculitis. J Clin Invest (2013) 1.99
The role of neutrophils in the induction of glomerulonephritis by anti-myeloperoxidase antibodies. Am J Pathol (2005) 1.97
Association between thyroid disease and its treatment with ANCA small-vessel vasculitis: a case-control study. Nephrol Dial Transplant (2007) 1.89
Epigenetic basis for aberrant upregulation of autoantigen genes in humans with ANCA vasculitis. J Clin Invest (2010) 1.87
Anti-LAMP-2 antibodies are not prevalent in patients with antineutrophil cytoplasmic autoantibody glomerulonephritis. J Am Soc Nephrol (2011) 1.82
Periodontal disease adversely affects the survival of patients with end-stage renal disease. Kidney Int (2009) 1.74
Patients with antineutrophil cytoplasmic antibody-associated vasculitis have defective Treg cell function exacerbated by the presence of a suppression-resistant effector cell population. Arthritis Rheum (2013) 1.70
Design of the Nephrotic Syndrome Study Network (NEPTUNE) to evaluate primary glomerular nephropathy by a multidisciplinary approach. Kidney Int (2013) 1.69
Aggravation of anti-myeloperoxidase antibody-induced glomerulonephritis by bacterial lipopolysaccharide: role of tumor necrosis factor-alpha. Am J Pathol (2005) 1.65
Rituximab therapy for membranous nephropathy: a systematic review. Clin J Am Soc Nephrol (2009) 1.62
SCreening for Occult REnal Disease (SCORED): a simple prediction model for chronic kidney disease. Arch Intern Med (2007) 1.56
The clinical course of ANCA small-vessel vasculitis on chronic dialysis. Kidney Int (2009) 1.54
Plasmapheresis therapy for diffuse alveolar hemorrhage in patients with small-vessel vasculitis. Am J Kidney Dis (2003) 1.53
DRB1*15 allele is a risk factor for PR3-ANCA disease in African Americans. J Am Soc Nephrol (2011) 1.51
Cutaneous and systemic manifestations of drug-induced vasculitis. Ann Pharmacother (2002) 1.48
Pathogenesis of vascular inflammation by anti-neutrophil cytoplasmic antibodies. J Am Soc Nephrol (2006) 1.48
Association of silica exposure with anti-neutrophil cytoplasmic autoantibody small-vessel vasculitis: a population-based, case-control study. Clin J Am Soc Nephrol (2007) 1.46
C5a receptor (CD88) blockade protects against MPO-ANCA GN. J Am Soc Nephrol (2013) 1.38
Clinical trials treating focal segmental glomerulosclerosis should measure patient quality of life. Kidney Int (2010) 1.38
Activation of mitochondrial apoptotic pathways in human renal allografts after ischemiareperfusion injury. Transplantation (2003) 1.35
Granulomatosis with polyangiitis (Wegener's): an alternative name for Wegener's granulomatosis. Ann Rheum Dis (2011) 1.33
Periodontal disease is associated with renal insufficiency in the Atherosclerosis Risk In Communities (ARIC) study. Am J Kidney Dis (2005) 1.31
HNF1B and PAX2 mutations are a common cause of renal hypodysplasia in the CKiD cohort. Pediatr Nephrol (2011) 1.28
High prevalence of sickle cell trait in African Americans with ESRD. J Am Soc Nephrol (2010) 1.23
Bone marrow-derived cells are sufficient and necessary targets to mediate glomerulonephritis and vasculitis induced by anti-myeloperoxidase antibodies. J Am Soc Nephrol (2006) 1.20
Glucocorticoids and relapse and infection rates in anti-neutrophil cytoplasmic antibody disease. Clin J Am Soc Nephrol (2011) 1.20
Molecular cloning, genomic structure, and expression analysis of MUC20, a novel mucin protein, up-regulated in injured kidney. J Biol Chem (2003) 1.17
ANCA are pathogenic--oh yes they are! J Am Soc Nephrol (2002) 1.15
Circumvention of normal constraints on granule protein gene expression in peripheral blood neutrophils and monocytes of patients with antineutrophil cytoplasmic autoantibody-associated glomerulonephritis. J Am Soc Nephrol (2004) 1.14
Urinary proteome of steroid-sensitive and steroid-resistant idiopathic nephrotic syndrome of childhood. Am J Nephrol (2006) 1.14
Decreased CD5⁺ B cells in active ANCA vasculitis and relapse after rituximab. Clin J Am Soc Nephrol (2013) 1.12
The association between abnormal birth history and growth in children with CKD. Clin J Am Soc Nephrol (2010) 1.12
Pathogenesis of antineutrophil cytoplasmic autoantibody vasculitis. Curr Opin Nephrol Hypertens (2011) 1.06
Induction of renal tubular cell apoptosis in focal segmental glomerulosclerosis: roles of proteinuria and Fas-dependent pathways. J Am Soc Nephrol (2004) 1.06
NPHS2 variation in focal and segmental glomerulosclerosis. BMC Nephrol (2008) 1.04
Pathophysiology of focal segmental glomerulosclerosis. Pediatr Nephrol (2007) 1.03
Association of glucocorticoid use and low 25-hydroxyvitamin D levels: results from the National Health and Nutrition Examination Survey (NHANES): 2001-2006. J Clin Endocrinol Metab (2011) 1.03
A pilot study using mycophenolate mofetil in relapsing or resistant ANCA small vessel vasculitis. Nephrol Dial Transplant (2005) 1.02
ANCA patients have T cells responsive to complementary PR-3 antigen. Kidney Int (2008) 1.02
Nosology of primary vasculitis. Curr Opin Rheumatol (2007) 1.01
Anti-neutrophil cytoplasmic (ANCA) and anti-glomerular basement membrane (GBM) autoantibodies in necrotizing and crescentic glomerulonephritis. Semin Immunopathol (2007) 1.01
Community perspectives on kidney disease and health promotion from at-risk populations in rural North Carolina, USA. Rural Remote Health (2010) 1.01
Fostering innovation, advancing patient safety: the kidney health initiative. Clin J Am Soc Nephrol (2013) 1.00
Successful treatment of diffuse alveolar hemorrhage with activated factor VII. Ann Intern Med (2004) 0.99
Expression profile of leukocyte genes activated by anti-neutrophil cytoplasmic autoantibodies (ANCA). Kidney Int (2002) 0.98
Granulomatosis with polyangiitis (Wegener's): an alternative name for Wegener's granulomatosis. J Am Soc Nephrol (2011) 0.98
New insight into the pathogenesis of vasculitis associated with antineutrophil cytoplasmic autoantibodies. Curr Opin Rheumatol (2008) 0.97
Novel effects of neutrophil-derived proteinase 3 and elastase on the vascular endothelium involve in vivo cleavage of NF-kappaB and proapoptotic changes in JNK, ERK, and p38 MAPK signaling pathways. J Am Soc Nephrol (2002) 0.97
Predictors of treatment outcomes in ANCA-associated vasculitis with severe kidney failure. Clin J Am Soc Nephrol (2014) 0.96
Proteinase 3 sidesteps caspases and cleaves p21(Waf1/Cip1/Sdi1) to induce endothelial cell apoptosis. Kidney Int (2004) 0.95
Recombinant tissue plasminogen activator infusion for hemodialysis catheter clearance. Pediatr Nephrol (2005) 0.95
Antibodies with dual reactivity to plasminogen and complementary PR3 in PR3-ANCA vasculitis. J Am Soc Nephrol (2008) 0.94
Obesity, albuminuria, and urinalysis findings in US young adults from the Add Health Wave III study. Clin J Am Soc Nephrol (2007) 0.93
Myeloperoxidase interacts with endothelial cell-surface cytokeratin 1 and modulates bradykinin production by the plasma Kallikrein-Kinin system. Am J Pathol (2007) 0.93
Urinary cytokines and steroid responsiveness in idiopathic nephrotic syndrome of childhood. Am J Nephrol (2007) 0.93
Various forms of life in antineutrophil cytoplasmic antibody-associated vasculitis. Ann Intern Med (2006) 0.92
Rituximab in ANCA-associated disease. N Engl J Med (2010) 0.92
Survival of liver transplant candidates with acute renal failure receiving renal replacement therapy. Kidney Int (2005) 0.91
Gene expression profiles of circulating leukocytes correlate with renal disease activity in IgA nephropathy. Kidney Int (2004) 0.91
Controversies in small vessel vasculitis--comparing the rheumatology and nephrology views. Curr Opin Rheumatol (2007) 0.90
Pharmacokinetics of mycophenolic acid in patients with lupus nephritis. Pharmacotherapy (2009) 0.89
Sera from patients with collapsing focal segmental glomerulosclerosis increase albumin permeability of isolated glomeruli. J Lab Clin Med (2004) 0.89
Cyclophosphamide and 4-hydroxycyclophosphamide pharmacokinetics in patients with glomerulonephritis secondary to lupus and small vessel vasculitis. Br J Clin Pharmacol (2012) 0.89
New insights that link microbes with the generation of antineutrophil cytoplasmic autoantibodies: the theory of autoantigen complementarity. Curr Opin Nephrol Hypertens (2005) 0.88
Severe periodontitis is associated with low serum albumin among patients on maintenance hemodialysis therapy. Clin J Am Soc Nephrol (2007) 0.88
Removing antibody and preserving glomeruli in ANCA small-vessel vasculitis. J Am Soc Nephrol (2007) 0.86
High basal activity of the PTPN22 gain-of-function variant blunts leukocyte responsiveness negatively affecting IL-10 production in ANCA vasculitis. PLoS One (2012) 0.86
B cell-mediated pathogenesis of ANCA-mediated vasculitis. Semin Immunopathol (2014) 0.85
Serum matrix metalloproteinases MMP-2 and MMP-3 levels in dialysis patients vary independently of CRP and IL-6 levels. Nephron (2002) 0.84
Influence of clinical and demographic variables on mycophenolic acid pharmacokinetics in antineutrophil cytoplasmic antibody-associated vasculitis. Ann Pharmacother (2009) 0.84
Glomerular expression of transforming growth factor-beta (TGF-beta) isoforms in mice lacking CD2-associated protein. Pediatr Nephrol (2005) 0.84
Genetically determined severity of anti-myeloperoxidase glomerulonephritis. Am J Pathol (2013) 0.83
Longitudinal studies of patients with ANCA vasculitis demonstrate concurrent reactivity to complementary PR3 protein segments cPR3m and cPR3C and with no reactivity to cPR3N. Autoimmunity (2010) 0.83
Monitoring proteinase 3 antineutrophil cytoplasmic antibodies for detection of relapses in small vessel vasculitis. Clin Diagn Lab Immunol (2003) 0.82
Primum non nocere: Should adults with idiopathic FSGS receive steroids? Semin Nephrol (2003) 0.81
IL-17A in experimental glomerulonephritis: where does it come from? J Am Soc Nephrol (2010) 0.81
Report of an NIH task force on research priorities in chronic kidney disease in children. Pediatr Nephrol (2005) 0.81
CYP2C9 genotype and pharmacodynamic responses to losartan in patients with primary and secondary kidney diseases. Eur J Clin Pharmacol (2009) 0.81
Reengineering clinical operations in a medical practice to optimize the management of anemia of chronic kidney disease. Pharmacotherapy (2007) 0.81
Use of enantiomeric bupropion and hydroxybupropion to assess CYP2B6 activity in glomerular kidney diseases. J Clin Pharmacol (2010) 0.80
Altered mRNA expression in renal biopsy tissue from patients with IgA nephropathy. Kidney Int (2003) 0.80
Sickle trait in African-American hemodialysis patients and higher erythropoiesis-stimulating agent dose. J Am Soc Nephrol (2014) 0.80
Renal function and proteinuria after successful immunosuppressive therapies in patients with FSGS. Clin J Am Soc Nephrol (2012) 0.79
The use of levo-carnitine in children with renal disease: a review and a call for future studies. Pediatr Nephrol (2005) 0.79
L1. Pathogenesis of ANCA-associated vasculitis: observations, theories and speculations. Presse Med (2013) 0.79